J W Paxton|F J Rowell - JoVE Visualize

Showing results (51-60 of 106) with videos related to

Pageof 11

Sort By:

The Analyst|November 1, 1994

Enzyme linked immunosorbent assay for ceftazidime in airborne samplesC Farrell, F J Rowell, C D'Silva, et al.

Journal of Chromatography. B, Biomedical Sciences and Applications|June 22, 2001

Determination of the covalent adducts of the novel anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid in biological samples by high-performance liquid chromatographyS Zhou, J W Paxton, M D Tingle, et al.

British Journal of Clinical Pharmacology|April 1, 1981

Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitroF J Rowell, S M Hui, A F Fairbairn, et al.

Annals of Clinical Biochemistry|September 1, 1986

Single-reagent polarisation fluoroimmunoassay for cotinine (a nicotine metabolite) in urineM C Hansel, F J Rowell, J Landon, et al.

Journal of Chromatography. B, Biomedical Sciences and Applications|June 22, 2001

Determination of unbound concentration of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in human plasma by ultrafiltration followed by high-performance liquid chromatography with fluorimetric detectionS Zhou, J W Paxton, M D Tingle, et al.

The Journal of Pharmacy and Pharmacology|May 9, 2001

Reversible binding of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid to plasma proteins and its distribution into blood cells in various speciesS Zhou, J W Paxton, P Kestell, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2000

Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acidS Zhou, J W Paxton, M D Tingle, et al.

Therapeutic Drug Monitoring|January 1, 1982

Direct determination of phenobarbital in serum or plasma by polarization fluoroimmunoassayA M Sidki, M Pourfarzaneh, F J Rowell, et al.

Epilepsia|September 1, 1992

Blood-brain barrier penetration of felbamateE M Cornford, D Young, J W Paxton, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1992

Intraperitoneal administration of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in the mouse: bioavailability, pharmacokinetics and toxicity after a single doseS M Evans, D Young, I G Robertson, et al.

Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:

Pageof 11

The Analyst|November 1, 1994

Enzyme linked immunosorbent assay for ceftazidime in airborne samplesC Farrell, F J Rowell, C D'Silva, et al.

Journal of Chromatography. B, Biomedical Sciences and Applications|June 22, 2001

Determination of the covalent adducts of the novel anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid in biological samples by high-performance liquid chromatographyS Zhou, J W Paxton, M D Tingle, et al.

British Journal of Clinical Pharmacology|April 1, 1981

Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitroF J Rowell, S M Hui, A F Fairbairn, et al.

Annals of Clinical Biochemistry|September 1, 1986

Single-reagent polarisation fluoroimmunoassay for cotinine (a nicotine metabolite) in urineM C Hansel, F J Rowell, J Landon, et al.

Journal of Chromatography. B, Biomedical Sciences and Applications|June 22, 2001

Determination of unbound concentration of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in human plasma by ultrafiltration followed by high-performance liquid chromatography with fluorimetric detectionS Zhou, J W Paxton, M D Tingle, et al.

The Journal of Pharmacy and Pharmacology|May 9, 2001

Reversible binding of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid to plasma proteins and its distribution into blood cells in various speciesS Zhou, J W Paxton, P Kestell, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2000

Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acidS Zhou, J W Paxton, M D Tingle, et al.

Therapeutic Drug Monitoring|January 1, 1982

Direct determination of phenobarbital in serum or plasma by polarization fluoroimmunoassayA M Sidki, M Pourfarzaneh, F J Rowell, et al.

Epilepsia|September 1, 1992

Blood-brain barrier penetration of felbamateE M Cornford, D Young, J W Paxton, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1992

Intraperitoneal administration of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in the mouse: bioavailability, pharmacokinetics and toxicity after a single doseS M Evans, D Young, I G Robertson, et al.

Pageof 11